How big is the Contract Research Organization (CRO) market?

The contract research organization (cro) market size is estimated to grow at $63.35 billion in 2024-2028. <a href='https://www.technavio.com/report/contract-research-organization-cro-market-industry-analysis'>Read More</a>

Which segment accounted for the largest Contract Research Organization (CRO) market share?

Market segmentation by application (Clinical research, Early phase development, Laboratory, and Regulatory consulting), end-user (Pharmaceutical and biopharmaceutical companies, Medical device companies, Academic institutes, and Rest .... <a href='https://www.technavio.com/report/contract-research-organization-cro-market-industry-analysis'>Read More</a>

Who are the key players in the Contract Research Organization (CRO) market?

BioAgile Therapeutics Pvt. Ltd, Charles River Laboratories International Inc., Clinical Trial Service B.V., CTI Clinical Trial and Consulting Inc., Ergomed Plc, Eurofins Scientific SE, .... <a href='https://www.technavio.com/report/contract-research-organization-cro-market-industry-analysis'>Read More</a>

What are the factors driving the Contract Research Organization (CRO) market?

The key factors driving the contract research organization (cro) market growth are: Growth of biopharmaceutical industry Increasing number of clinical trials</.... <a href='https://www.technavio.com/report/contract-research-organization-cro-market-industry-analysis'>Read More</a>

Contract Research Organization (CRO) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Published: Nov 2023
Pages: 174
SKU: IRTNTR73340

Enjoy complimentary customisation on priority with our Enterprise License!

Contract Research Organization Market Size 2024-2028

The contract research organization (CRO) market size is forecast to increase by USD 63.35 billion at a CAGR of 12.61% between 2023 and 2028. The market is experiencing significant growth due to the expanding biopharmaceutical industry and the increasing number of clinical trials in various therapeutic areas, including CNS disorders therapeutics, cardiology research, metabolic disorders, and infectious disease trials. Pharmaceutical sponsors and providers of medical devices are outsourcing an increasing number of clinical trials to CROs to reduce costs, improve efficiency, and enhance the quality of research. However, intellectual property (IP) issues pose a challenge to the growth of the CRO industry, as disputes over IP ownership and licensing can lead to delays and increased costs. To remain competitive, CROs must provide innovative solutions to IP challenges and ensure compliance with regulatory requirements.

What will be the Size of the Contract Research Organization Market During the Forecast Period?

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global contract research organization (CRO) market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global contract research organization (cro) market 2018 - 2022 ($ billion)

4.2 Application Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ billion)

4.3 End-user Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ billion)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Application - Market share 2023-2028 (%)

6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application

6.3 Clinical research - Market size and forecast 2023-2028
- Exhibit 34: Chart on Clinical research - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Clinical research - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Clinical research - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Clinical research - Year-over-year growth 2023-2028 (%)

6.4 Early phase development - Market size and forecast 2023-2028
- Exhibit 38: Chart on Early phase development - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Early phase development - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Early phase development - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Early phase development - Year-over-year growth 2023-2028 (%)

6.5 Laboratory - Market size and forecast 2023-2028
- Exhibit 42: Chart on Laboratory - Market size and forecast 2023-2028 ($ billion)
- Exhibit 43: Data Table on Laboratory - Market size and forecast 2023-2028 ($ billion)
- Exhibit 44: Chart on Laboratory - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Laboratory - Year-over-year growth 2023-2028 (%)

6.6 Regulatory consulting - Market size and forecast 2023-2028
- Exhibit 46: Chart on Regulatory consulting - Market size and forecast 2023-2028 ($ billion)
- Exhibit 47: Data Table on Regulatory consulting - Market size and forecast 2023-2028 ($ billion)
- Exhibit 48: Chart on Regulatory consulting - Year-over-year growth 2023-2028 (%)
- Exhibit 49: Data Table on Regulatory consulting - Year-over-year growth 2023-2028 (%)

6.7 Market opportunity by Application
- Exhibit 50: Market opportunity by Application ($ billion)
- Exhibit 51: Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by End-user

7.1 Market segments
- Exhibit 52: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 53: Data Table on End-user - Market share 2023-2028 (%)

7.2 Comparison by End-user
- Exhibit 54: Chart on Comparison by End-user
- Exhibit 55: Data Table on Comparison by End-user

7.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028
- Exhibit 56: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 57: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 58: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)

7.4 Medical device companies - Market size and forecast 2023-2028
- Exhibit 60: Chart on Medical device companies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 61: Data Table on Medical device companies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 62: Chart on Medical device companies - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Medical device companies - Year-over-year growth 2023-2028 (%)

7.5 Academic institutes - Market size and forecast 2023-2028
- Exhibit 64: Chart on Academic institutes - Market size and forecast 2023-2028 ($ billion)
- Exhibit 65: Data Table on Academic institutes - Market size and forecast 2023-2028 ($ billion)
- Exhibit 66: Chart on Academic institutes - Year-over-year growth 2023-2028 (%)
- Exhibit 67: Data Table on Academic institutes - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by End-user
- Exhibit 68: Market opportunity by End-user ($ billion)
- Exhibit 69: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 71: Chart on Market share by geography 2023-2028 (%)
- Exhibit 72: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 73: Chart on Geographic comparison
- Exhibit 74: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 China - Market size and forecast 2023-2028
- Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)

9.9 Germany - Market size and forecast 2023-2028
- Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.10 Canada - Market size and forecast 2023-2028
- Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.11 UK - Market size and forecast 2023-2028
- Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 111: Market opportunity by geography ($ billion)
- Exhibit 112: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 113: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 114: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 115: Overview on factors of disruption

11.4 Industry risks
- Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 117: Vendors covered

12.2 Market positioning of vendors
- Exhibit 118: Matrix on vendor position and classification

12.3 BioAgile Therapeutics Pvt. Ltd
- Exhibit 119: BioAgile Therapeutics Pvt. Ltd - Overview
- Exhibit 120: BioAgile Therapeutics Pvt. Ltd - Product / Service
- Exhibit 121: BioAgile Therapeutics Pvt. Ltd - Key offerings

12.4 Charles River Laboratories International Inc.
- Exhibit 122: Charles River Laboratories International Inc. - Overview
- Exhibit 123: Charles River Laboratories International Inc. - Business segments
- Exhibit 124: Charles River Laboratories International Inc. - Key news
- Exhibit 125: Charles River Laboratories International Inc. - Key offerings
- Exhibit 126: Charles River Laboratories International Inc. - Segment focus

12.5 CTI Clinical Trial and Consulting Inc.
- Exhibit 127: CTI Clinical Trial and Consulting Inc. - Overview
- Exhibit 128: CTI Clinical Trial and Consulting Inc. - Product / Service
- Exhibit 129: CTI Clinical Trial and Consulting Inc. - Key offerings

12.6 Ergomed Plc
- Exhibit 130: Ergomed Plc - Overview
- Exhibit 131: Ergomed Plc - Business segments
- Exhibit 132: Ergomed Plc - Key news
- Exhibit 133: Ergomed Plc - Key offerings
- Exhibit 134: Ergomed Plc - Segment focus

12.7 Eurofins Scientific SE
- Exhibit 135: Eurofins Scientific SE - Overview
- Exhibit 136: Eurofins Scientific SE - Business segments
- Exhibit 137: Eurofins Scientific SE - Key news
- Exhibit 138: Eurofins Scientific SE - Key offerings
- Exhibit 139: Eurofins Scientific SE - Segment focus

12.8 ICON plc
- Exhibit 140: ICON plc - Overview
- Exhibit 141: ICON plc - Product / Service
- Exhibit 142: ICON plc - Key offerings

12.9 IQVIA Holdings Inc.
- Exhibit 143: IQVIA Holdings Inc. - Overview
- Exhibit 144: IQVIA Holdings Inc. - Business segments
- Exhibit 145: IQVIA Holdings Inc. - Key news
- Exhibit 146: IQVIA Holdings Inc. - Key offerings
- Exhibit 147: IQVIA Holdings Inc. - Segment focus

12.10 Konecranes
- Exhibit 148: Konecranes - Overview
- Exhibit 149: Konecranes - Business segments
- Exhibit 150: Konecranes - Key offerings
- Exhibit 151: Konecranes - Segment focus

12.11 Laboratory Corp. of America Holdings
- Exhibit 152: Laboratory Corp. of America Holdings - Overview
- Exhibit 153: Laboratory Corp. of America Holdings - Business segments
- Exhibit 154: Laboratory Corp. of America Holdings - Key news
- Exhibit 155: Laboratory Corp. of America Holdings - Key offerings
- Exhibit 156: Laboratory Corp. of America Holdings - Segment focus

12.12 Medpace Holdings Inc.
- Exhibit 157: Medpace Holdings Inc. - Overview
- Exhibit 158: Medpace Holdings Inc. - Product / Service
- Exhibit 159: Medpace Holdings Inc. - Key offerings

12.13 Novotech Health Holdings
- Exhibit 160: Novotech Health Holdings - Overview
- Exhibit 161: Novotech Health Holdings - Product / Service
- Exhibit 162: Novotech Health Holdings - Key offerings

12.14 Parexel International Corp.
- Exhibit 163: Parexel International Corp. - Overview
- Exhibit 164: Parexel International Corp. - Product / Service
- Exhibit 165: Parexel International Corp. - Key news
- Exhibit 166: Parexel International Corp. - Key offerings

12.15 Syneos Health Inc.
- Exhibit 167: Syneos Health Inc. - Overview
- Exhibit 168: Syneos Health Inc. - Business segments
- Exhibit 169: Syneos Health Inc. - Key offerings
- Exhibit 170: Syneos Health Inc. - Segment focus

12.16 Thermo Fisher Scientific Inc.
- Exhibit 171: Thermo Fisher Scientific Inc. - Overview
- Exhibit 172: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 173: Thermo Fisher Scientific Inc. - Key news
- Exhibit 174: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 175: Thermo Fisher Scientific Inc. - Segment focus

12.17 WuXi AppTec Co. Ltd.
- Exhibit 176: WuXi AppTec Co. Ltd. - Overview
- Exhibit 177: WuXi AppTec Co. Ltd. - Business segments
- Exhibit 178: WuXi AppTec Co. Ltd. - Key offerings
- Exhibit 179: WuXi AppTec Co. Ltd. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 180: Inclusions checklist
- Exhibit 181: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 182: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 183: Research methodology
- Exhibit 184: Validation techniques employed for market sizing
- Exhibit 185: Information sources